A Study to Evaluate the Efficacy of Sublingual Cannabinoid Based Medicine Extract Compound Compared with Placebo for the Treatment of Sleep Disorders Due to Insomnia

Project Details

StatusFinished
Effective start/end date4/09/1731/01/21

Funding

  • Zelda Therapeutics Ltd: A$43,822.00
  • Zelda Therapeutics Ltd: A$309,221.00
  • Zelda Therapeutics Ltd: A$90,957.00
  • Zelda Therapeutics Ltd: A$149,583.00